Terms: = Gastric cancer AND BTG1, P62324, 694, ENSG00000133639 AND Treatment
17 results:
1. Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold.
Schmäche T; Fohgrub J; Klimova A; Laaber K; Drukewitz S; Merboth F; Hennig A; Seidlitz T; Herbst F; Baenke F; Ada AM; Groß T; Wenzel C; Ball CR; Praetorius C; Schmidt T; Ringelband-Schilling B; Koschny R; Stenzinger A; Roeder I; Jaeger D; Zeissig S; Welsch T; Aust D; Glimm H; Folprecht G; Weitz J; Haag GM; Stange DE
Mol Cancer; 2024 Jan; 23(1):10. PubMed ID: 38200602
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic nomograms for gastric carcinoma after D2 + total gastrectomy to assist decision-making for postoperative treatment: based on Lasso regression.
Li Y; Bai M; Gao Y
World J Surg Oncol; 2023 Jul; 21(1):207. PubMed ID: 37475024
[TBL] [Abstract] [Full Text] [Related]
3. sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker Research.
Wernly S; Paar V; Völkerer A; Semmler G; Datz C; Lichtenauer M; Wernly B
Dig Dis Sci; 2023 Aug; 68(8):3293-3299. PubMed ID: 37338618
[TBL] [Abstract] [Full Text] [Related]
4. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract] [Full Text] [Related]
5. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
6. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
7. Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data.
Lin JX; Wang ZK; Wang W; Desiderio J; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Parisi A; Zhou ZW; Huang CM
BMC Cancer; 2019 Nov; 19(1):1048. PubMed ID: 31694573
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node-Positive gastric cancer Treated with Different Adjuvant Protocols.
Yu JI; Lim DH; Lee J; Kang WK; Park SH; Park JO; Park YS; Lim HY; Kim ST; Lee SJ; Kim S; Sohn TS; Lee JH; An JY; Choi MG; Bae JM; Yoo H; Kim K
Cancer Res Treat; 2019 Jul; 51(3):876-885. PubMed ID: 30282450
[TBL] [Abstract] [Full Text] [Related]
9. The RESTORE Randomized Controlled Trial: Impact of a Multidisciplinary Rehabilitative Program on Cardiorespiratory Fitness in Esophagogastric cancer Survivorship.
O'Neill LM; Guinan E; Doyle SL; Bennett AE; Murphy C; Elliott JA; OʼSullivan J; Reynolds JV; Hussey J
Ann Surg; 2018 Nov; 268(5):747-755. PubMed ID: 30004915
[TBL] [Abstract] [Full Text] [Related]
10. Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.
Kim SY; Yoon MJ; Park YI; Kim MJ; Nam BH; Park SR
Gastric Cancer; 2018 May; 21(3):453-463. PubMed ID: 28828688
[TBL] [Abstract] [Full Text] [Related]
11. Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-treatment Evaluation of Locally Advanced gastric cancer.
Wang X; Wei Y; Xue Y; Lu P; Yu L; Shen B
PLoS One; 2016; 11(12):e0166836. PubMed ID: 27936109
[TBL] [Abstract] [Full Text] [Related]
12. [Methylation and demethylation of SOX2 gene promoter in BGC-823 gastric cancer cells].
Wei B; Liu G; Cai HL; Li GP; Huang HQ; Luo Q; Huang ZJ
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(32):2548-53. PubMed ID: 27596549
[TBL] [Abstract] [Full Text] [Related]
13. Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence.
Jiang Y; Xu H; Jiang H; Ding S; Zheng T
Cancer Biomark; 2016 Mar; 16(4):523-8. PubMed ID: 27062567
[TBL] [Abstract] [Full Text] [Related]
14. btg1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract] [Full Text] [Related]
15. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract] [Full Text] [Related]
16. The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis.
Han M; Lv S; Zhang Y; Yi R; Huang B; Fu H; Bian R; Li X
Tumour Biol; 2014 May; 35(5):4589-97. PubMed ID: 24464926
[TBL] [Abstract] [Full Text] [Related]
17. [Lymph node dissection in patients with cancer of the proximal part of the stomach].
Davydov MI; Germanov AB; Stilidi IS; Kuz'michev VA; Arzykulov ZhA
Khirurgiia (Mosk); 1995; (5):41-6. PubMed ID: 7474704
[TBL] [Abstract] [Full Text] [Related]
